Granuloma formation around a retained perclose S suture presenting 12 months after implantation

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 7, 2004, Pages 759-761

  Doshi, Sagar N ^a   Smith, Simon ^a   Townend, Jonathan N ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLACTIN; POLYPROPYLENE;

ADULT; ANGIOCARDIOGRAPHY; ARTERIOTOMY; ARTICLE; CASE REPORT; DEVICE; ECHOGRAPHY; FEMORAL ARTERY; GRANULOMA; HEART CATHETERIZATION; HEMOSTASIS; HOSPITAL DISCHARGE; HUMAN; MALE; MOBILIZATION; PRIORITY JOURNAL; SURGICAL INFECTION; SURGICAL WOUND; SUTURE; WOUND CLOSURE;

EID: 3042853824     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000133540.82436.80     Document Type: Article

References (17)

1. Applegate RJ, Grabarczyk MA, Little WC, et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol 2002; 40:78-83.
2. Assali AR, Sdringola S, Moustapha A, et al. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Cathet Cardiovasc Intervent 2003; 58:1-5.
3. Baim DS, Knopf WD, Hinohara T, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate and discharge (STAND I and STAND II) trials. Am J Cardiol 2000; 85:864-869.
4. Chamberlin JR, Lardi AB, McKeever LS, et al. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Cathet Cardiovasc Intervent 1999; 47:143-147.
5. Cura FA, Kapadia SR, L'Allier PL, et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol 2000; 86:780-782.
6. Gerckens U, Cattelaens N, Lampe EG, Grube E. Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol 1999; 83:1658-1663.
7. Starnes BW, O'Donnell SD, Gillespie DL, et al. Percutaneous arterial closure in peripheral vascular disease: a prospective randomized evaluation of the Perclose device. J Vasc Surg 2003; 38:263-271.
8. Wetter DR, Rickli H, von Smekal A, Amann FW. Early sheath removal after coronary artery interventions with use of a suture-mediated closure device: clinical outcome and results of Doppler US evaluation. J Vasc Interv Radiol 2000; 11:1033-1037.
9. Hoffer EK, Bloch RD. Percutaneous arterial closure devices. J Vasc Interv Radiol 2003; 14:865-885.
10. Mehta H, Fleisch M, Chatterjee T, et al. Novel femoral artery puncture closure device in patients undergoing interventional and diagnostic cardiac procedures. J Invas Cardiol 2002; 14:9-12.
11. Boston US, Panneton JM, Hofer JM, et al. Infectious and ischemic complications from percutaneous closure devices used after vascular access. Ann Vasc Surg 2003; 17:66-71.
12. Geary K, Landers JT, Fiore W, Riggs P. Management of infected femoral closure devices. Cardiovasc Surg 2002; 10:161-163.
13. Heck DV, Muldowney S, McPherson SH. Infectious complications of Perclose for closure of femoral artery punctures. J Vasc Interv Radiol 2002; 13:430-431.
14. Johanning JM, Franklin DP, Elmore JR, Han DC. Femoral artery infections associated with percutaneous arterial closure devices. J Vasc Surg 2001; 34:983-985.
15. Pipkin W, Brophy C, Nesbit R, Mondy JS III. Early experience with infectious complications of percutaneous femoral artery closure devices. J Vasc Surg 2000; 32:205-208.
16. Smith TP, Cruz CP, Moursi MM, Eidt JF. Infectious complications resulting from use of hemostatic puncture closure devices. Am J Surg 2001; 182:658-662.
17. Sesana M, Vaghetti M, Albiero R, et al. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invas Cardiol 2000; 12:395-399.